Credicorp Ltd.

The stock sits in a strong multi-month uptrend, trading well above its 200-day moving average and only a few points below its 52-week high. That keeps the regime constructive, with momentum still favoring buyers unless it loses the recent breakout area.

Street sentiment is constructive: consensus is Buy, with a $414 median target versus a $395.49 share price. Recent action has turned more bullish, led by Morgan Stanley’s upgrade to Overweight and UBS/HSBC raising targets and ratings in May and June.

The earnings pattern is mixed but still healthy, with 5 beats in the last 7 quarters and a 4.5% beat in the latest reported quarter. Next-year EPS is modeled higher at 33.78, so shareholders should watch whether loan growth, margins, and credit costs keep supporting that step-up.

Recent insider activity leans negative on signal, with two discretionary sales and no offsetting buys. The CEO sold 3,500 shares and the CFO sold 1,073 shares; the rest of the filings are non-economic entries and do not change the read.

Profitability is strong, anchored by a 32.9% net margin and 19.15% ROE. Growth is still solid, with revenue up 25.6% year over year and earnings up 16.1%, while free cash flow of $8.37 billion and net cash of $9.98 billion leave the balance sheet flexible.

Credicorp’s diversified banking, insurance, microfinance, and asset-management mix gives it a broader earnings base than a plain-vanilla regional lender. At 15.07x earnings, valuation is not stretched for a high-ROE franchise, especially with the stock near its high end of the 52-week range.